Humira 40 mg solution for injection in pre-filled pen
Sponsors
Abbvie Deutschland GmbH & Co. KG, Assistance Publique Hopitaux De Paris, Centre Hospitalier Universitaire De Saint Etienne, Diakonhjemmet Sykehus AS, University Of Medicine And Pharmacy Carol Davila Bucharest, Medical University Of Vienna, Karolinska University Hospital, IRCCS Istituto Giannina Gaslini
Conditions
Juvenile idiopathic arthritisRheumatoid ArthritisRheumatoid arthritisand pan-uveitisnoninfectious uveitisposteriorrecently active non-infectious intermediate
Phase 3
A Phase 3b/4 Randomized, Double-Blind, Double-Dummy, Active-Comparator Controlled Study, Comparing the Efficacy and Safety of Upadacitinib Versus Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis on a stable background of MTX and who had an Inadequate Response or Intolerance to a Single TNF Inhibitor (SELECT- SWITCH)
Active, not recruitingCTIS2022-502578-18-00
Start: 2023-11-07Target: 165Updated: 2025-09-16
Randomized controlled multicenter study comparing efficacy and safety of adalimumab to that of mycophenolate mofetil in steroid dependent non-infectious uveitis. FOCUS: treatment FOr Corticosteroid dependent UveitiS
RecruitingCTIS2023-505112-38-00
Start: 2024-07-01Target: 120Updated: 2025-04-22
Phase 4
A multi-center, open, randomized, 18-month, parallel-group, superiority study to compare the effect of proactive therapeutic drug monitoring versus standard of care with regards to maintenance of sustained disease control without flare in adults with rheumatoid arthritis treated with a subcutaneous tumor necrosis factor inhibitor
RecruitingCTIS2023-510184-35-00
Start: 2024-08-20Target: 410Updated: 2025-09-12
Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized clinical trial comparing early versus late drug withdrawal combining imaging and multi-Omics.
RecruitingCTIS2024-514732-24-00
Start: 2025-04-28Target: 328Updated: 2025-08-26
Evaluation of a therapeutic de-eScalation strategy based on therapeutic drug MOnitOring in chronic non-infectious uveitis Treated witH adalimumab
Not yet recruitingCTIS2023-509733-39-00
Target: 320Updated: 2025-04-28